Predicting hyperprogressive disease in patients with advanced hepatocellular carcinoma treated with anti-programmed cell death 1 therapy

BACKGROUND: Hyperprogressive disease (HPD) is a new progressive pattern in patients with advanced hepatocellular carcinoma (HCC) treated with programmed cell death 1 (PD-1) inhibitors. We aimed to investigate risk factors associated with HPD in advanced HCC patients undergoing anti-PD-1 therapy. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lu, Wu, Lingeng, Chen, Qiuying, Zhang, Bin, Liu, Jing, Liu, Shuyi, Mo, Xiaokai, Li, Minmin, Chen, Zhuozhi, Chen, Luyan, You, Jingjing, Jin, Zhe, Chen, Xudong, Zhou, Zejian, Zhang, Shuixing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846667/
https://www.ncbi.nlm.nih.gov/pubmed/33554079
http://dx.doi.org/10.1016/j.eclinm.2020.100673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846667/
https://www.ncbi.nlm.nih.gov/pubmed/33554079
http://dx.doi.org/10.1016/j.eclinm.2020.100673

Ejemplares similares